Acute exacerbations of fibrotic hypersensitivity pneumonitis: A case series

Chest

Volumn 134, Issue 4, 2008, Pages 844-850

  Olson, Amy L ^a   Huie, Tristan J ^a   Groshong, Steve D ^b   Cosgrove, Gregory P ^b   Janssen, William J ^b   Schwarz, Marvin I ^a   Brown, Kevin K ^b   Frankel, Stephen K ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Acute exacerbation; Diffuse alveolar damage; Diffuse alveolar hemorrhage; Fibrosis; Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ASSISTED VENTILATION; CASE REPORT; COUGHING; DISEASE EXACERBATION; DRUG MEGADOSE; DYSPNEA; FEMALE; FIBROTIC ALLERGIC PNEUMONITIS; HUMAN; HUMAN CELL; LUNG BIOPSY; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 54249141811     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0428     Document Type: Article

References (26)

1. American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165:277-304
2. Panos RJ, Mortenson RL, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990; 88:396-404
3. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142:963-967
4. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171:1040 -1047
5. King TE, Safrin S, Starko KM, et al. Analysis of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. Chest 2005; 127:171-177
6. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 16:636-643
7. Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am J Clin Pathol 2003; 119:709-714
8. Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other that idiopathic pulmonary fibrosis. Chest 2007; 132:214-220
9. Churg A, Müller NL, Silva IS, et al. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 2007; 31:277-284
10. Selman M. Hypersensitivity pneumonitis. In: Schwarz MI, King TE, eds. Interstitial lung disease. 4th ed. Ontario, Canada: BC Decker, 2003; 452-484
11. Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients hypersensitivity pneumonitis. Am J Med 2004; 116:662-668
12. Richardsen HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. J Allergy Clin Immunol 1989; 84:839-844
13. Vourlekis JS, Schwarz MI, Cool CD, et al. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002; 112:490-493
14. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 1992; 103:1808-1812
15. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997; 168:79-83
16. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003; 22:821-826
17. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 2005; 128:3310-3315
18. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006; 27:143-150
19. Gong MN, Mark EJ. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. Case 40-2002: a 56-year-old man with rapidly worsening dyspnea. N Engl J Med 2002; 347:2149-2157
20. Ohtani Y, Inase N, Miyake S, et al. Fatal outcome in chronic bird fancier's lung [letter]. Am J Med 2002; 112:588-590
21. Hyzy R, Huang S, Myers J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Chest 2007; 132:1652-1658
22. Kuwano K, Fukuyama S, Ikegami T, et al. An autopsy care of idiopathic interstitial pneumonia with diffuse alveolar hemorrhage due to acute exacerbation [in Japanese]. Nihoh Kokyuki Gakkai Zasshi 2001; 39:787-791
23. King TE Jr. Idiopathic interstitial pneumonias. In: Schwarz MI, King TE, eds. Interstitial Lung Disease. 4th ed. Ontario, Canada: BC Decker, 2003; 701-786
24. Salvioli B, Belmonte G, Stanghellini V, et al. Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 2006; 38:879-884
25. Husain A, Kumar V. The lung. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran: pathologic basis of disease. 7th ed. Philadelphia, PA: Elsevier Saunders, 2005; 715-716
26. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754